Detalhe da pesquisa
1.
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
Clin Infect Dis
; 78(2): 476-483, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864849
2.
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.
Influenza Other Respir Viruses
; 18(5): e13294, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716791